enow.com Web Search

  1. Ads

    related to: sirolimus antifungal

Search results

  1. Results from the WOW.Com Content Network
  2. Sirolimus - Wikipedia

    en.wikipedia.org/wiki/Sirolimus

    Sirolimus, also known as rapamycin and sold under the brand name Rapamune among others, is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumour (PEComa).

  3. Streptomyces hygroscopicus - Wikipedia

    en.wikipedia.org/wiki/Streptomyces_hygroscopicus

    Sirolimus (also known as rapamycin) is an antifungal and immunosuppressant that has been isolated from S. hygroscopicus from soil samples from Easter Island. [4] Ascomycin is another immunosuppressant produced by some strains of S. hygroscopicus; it has a similar structure to sirolimus and can be used to treat autoimmune diseases and skin diseases and can help prevent rejection after an organ ...

  4. Why I Started and Stopped Taking the “Anti-Aging ... - AOL

    www.aol.com/why-started-stopped-taking-anti...

    When my body returns to baseline levels I will consider re-taking sirolimus starting with a much lower dose, like 0.5 mg or 1 mg per week, and very gradually increasing the dose, without making ...

  5. Immunosuppressive drug - Wikipedia

    en.wikipedia.org/wiki/Immunosuppressive_drug

    Sirolimus (rapamycin, trade name Rapamune) is a macrolide lactone, produced by the actinomycete bacterium Streptomyces hygroscopicus. It is used to prevent rejection reactions. Although it is a structural analogue of tacrolimus, it acts somewhat differently and has different side-effects.

  6. Macrolide - Wikipedia

    en.wikipedia.org/wiki/Macrolide

    Some macrolides have antibiotic or antifungal activity and are used as pharmaceutical drugs. Rapamycin is also a macrolide and was originally developed as an antifungal, but has since been used as an immunosuppressant drug and is being investigated as a potential longevity therapeutic .

  7. The threat of fungal infections is growing. Why is it so hard ...

    www.aol.com/news/threat-fungal-infections...

    Last summer, the Food and Drug Administration denied an application for a new antifungal drug called olorofim, sending it back to the company with a request for more data. If approved, it would ...

  1. Ads

    related to: sirolimus antifungal